WorldLatestMedicineInformation(ElectronicVersion)2019Vo1.19No.61
104
sectionalstudy[J].Lancet,2016,4:e307-319.[28]Ene-IordacheB,PericoN,BikbovB,etal.Chronickidneydiseaseand
[17]HwangSJ,TsaiJC,ChenHC.Epidemiology,impactandpreventivecareofcardiovascularriskinsixregionsoftheworld(ISN-KDDC):Across-
chronickidneydiseaseinTaiwan[J].Nephrology,2010,15:3-9.sectionalstudy.LancetGlob[J].Health,2016,4:e307-319.
[18]LiuQ,LiZ,WangH,etal.Highprevalenceandassociatedriskfactorsfor[29]ChowKM,SzetoCC,KwanB,etal.Publiclacksknowledgeonchronic
impairedrenalfunctionandurinaryabnormalitiesinaruraladultpopulationkidneydisease:Telephonesurvey[J].HongKongMed.J,2014,20:139-144.
fromsouthernChina[J].PLoSOne,2012,7:e47-100.[30]LiPKT,KwanBC,LeungCB,etal.Prevalenceofsilentkidneydiseasein
[19]ChenN,WangW,HuangY,etal.Community-basedstudyonCKDsubjectsHongKong:ThescreeningforHongKongAsymptomaticRenalPopulation
andtheassociatedriskfactors[J].Nephrol.Dial.Transplant,2009,24:2117-andEvaluation(SHARE)program[J].KidneyInt.Suppl,2005,67:S36-40.
2123.[31]FoleyRN,CollinsAJ．End．stagerenaldiseaseintheUnitedStates：
[20]CoreshJ,Byrd-HoltD,AstorBC,etal.Chronickidneydiseaseawareness,anupdatefromtheUnitedStatesRenalDataSystem[J]．JAmSoc
prevalence,andtrendsamongU.S.adults,1999to2000[J].J.Am.Soc.Nephro1,2007,18:2644-2648.
Nephrol,2005,16:180-188.[32]CoreshJ,SelvinE,StevensLA,eta1．Prevalenceofchronickidneydiseasein
[21]CoreshJ,SelvinE,StevensLA,etal.PrevalenceofchronickidneydiseaseintheUnitedStates[J]．JAMA,2007,298:2038-2047.
theUnitedStates[J].JAMA,2007,298:2038-2047.[33]GargAX，KiberdBA，ClarkWF，etal．Albuminuriaandrenalinsufficiency
[22]PlantingaLC,BoulwareLE,CoreshJ,etal.Patientawarenessofchronickidneyprevalenceguidespopulationscreening：resultsfromtheNHANESIII[J]．
disease:Trendsandpredictors[J].Arch.Intern.Med,2008,168:2268-2275.KidneyInt,2002,61:2165-2175.
[23]VassalottiJA,LiS,McCulloughPA,BakrisGL.Kidneyearlyevaluation[34]MeguidElNahasA,BelloAK.Chronickidneydisease:theglobal
program:Acommunity-basedscreeningapproachtoaddressdisparitiesinchallenge[J].Lancet,2005,365:331-340.
chronickidneydisease[J].Semin.Nephrol,2010,30:66-73.[35]WangH,ZhangL,LvJ．Preventionoftheprogressionofchronickidney
[24]PlantingaLC,JohansenK,CrewsDC,etal.AssociationofCKDwithdisease：practiceinChina[J]．KidneyIntSuppl,2005,S63-7.
disabilityintheUnitedStates.Am.J.KidneyDis,2011,57:212-217.[36]张勉之,张敏英,沈伟梁.慢性肾功能衰竭原发病的流行病学研究[J].
[25]MinutoloR,DeNicolaL,MazzagliaG,etal.Detectionandawarenessof中国慢性病预防与控制,2004,12:1-72.
moderatetoadvancedCKDbyprimarycarepractitioners:Across-sectional[37]O''ShaughnessyMM,HoganSL,PoultonCJ,etal.Temporalanddemographic
studyfromItaly[J].Am.J.KidneyDis,2008,52:444-453.trendsinglomerulardiseaseepidemiologyinthesoutheasternUnitedStates,
[26]StackAG.Impactoftimingofnephrologyreferralandpre-ESRDcareon1986-2015[J].Clin.J.Am.Soc.Nephrol,2017,12:614-23.
mortalityriskamongnewESRDpatientsintheUnitedStates[J].Am.J.[38]NgJK,MaTK,LaiFM,etal.Causesofnephroticsyndromeandnephrotic-
KidneyDis,2003,41:310-318.rangeproteinuriaaredifferentinadultChinesepatients:Asinglecentrestudy
[27]NationalKidneyFoundation.K/DOQIclinicalpracticeguidelinesforover33years[J].Nephrology(Carlton),2017,23:565-572.
chronickidneydisease:Evaluation,classification,andstratification[J].Am.J.
KidneyDis,2002,39:S1-266.
（上接第101页）
[35]HM,MM,KO,etal.IncreasedexpressionofgenesforbasicfibroblastNutritionExaminationSurvey[J].BJUInt,2005,96(1):77-82.
growthfactorandtransforminggrowthfactortypebeta2inhumanbenign[43]BradleyCS,EricksonBA,MessersmithEE,etal.EvidenceoftheImpact
prostatichyperplasia[J].TheProstate,1990,16(1):71-80.ofDiet,FluidIntake,Caffeine,AlcoholandTobaccoonLowerUrinary
[36]TSM.CulturedhumanforeskinfibroblastsproduceafactorthatstimulatesTractSymptoms:ASystematicReview[J].JUrol,2017,198(5):1010-1020.
theirgrowthwithpropertiessimilartobasicfibroblastgrowthfactor.%JIn[44]卢智泉,王立华,贺振全,等.男性饮酒及体质指数与良性前列腺增生
VitroCellular&DevelopmentalBiology[J],1989,25(5):402-408.关系[J].中国公共卫生,2007,(12):1471-1473.
[37]SreenivasuluK,NandeeshaH,DorairajanLN,etal.Elevatedinsulinand[45]RaheemOA,ParsonsJK.Associationsofobesity,physicalactivityanddiet
reducedinsulinlikegrowthfactorbindingprotein-3/prostatespecificantigenwithbenignprostatichyperplasiaandlowerurinarytractsymptoms[J].Curr
ratiowithincreaseinprostatesizeinBenignProstaticHyperplasia[J].ClinOpinUrol,2014,24(1):10-14.
ChimActa,2017,469:37-41.[46]向玖琳.运动对肥胖小鼠良性前列腺增生的影响及其机制研究[D].上
[38]YangBY,JiangCY,DaiCY,etal.5-ARIinducesautophagyof海体育学院,2017.
prostateepithelialcellsthroughsuppressingIGF-1expressioninprostate[47]EspinosaG.Nutritionandbenignprostatichyperplasia[J].CurrOpinUrol,
fibroblasts[J].CellProlif,2019:e12590.2013,23(1):38-41.
[39]王刚,姚丽霞,李芳,等.转化生长因子β1在前列腺增生合并高血压[48]Schwarz,Silke,Obermüller-Jevic,etal.LycopeneInhibitsDisease
患者前列腺组织中的表达及意义[J].中外医疗,2015,34(3):85-86.ProgressioninPatientswithBenignProstateHyperplasia[J].TheJournalof
[40]齐建军,文娟,张黎月,等.糖尿病及吸烟指数与良性前列腺增生的相Nutrition,2008,138(1):49-53.
关性[J].山东医药,2010,50(39):3-5.[49]AdoriniL,PennaG,FibbiB,etal.VitaminDreceptoragoniststargetstatic,
[41]沈文,姚华强,邓志雄,等.良性前列腺增生与血管损害高危因素相关dynamic,andinflammatorycomponentsofbenignprostatichyperplasia[J].
性分析[J]中华男科学杂志,2010,16(1):29-33.AnnalsoftheNewYorkAcademyofSciences,2010,1193(1):146-152.
[42]RohrmannS,CrespoCJ,WeberJR,etal.Associationofcigarettesmoking,[50]卢智泉,张黎月,文娟,等.蛋白质摄入量与良性前列腺增生相关性分
alcoholconsumptionandphysicalactivitywithlowerurinarytractsymptoms析[J].中国公共卫生,2012,28(04):471-473.
inolderAmericanmen:findingsfromthethirdNationalHealthAnd
投稿邮箱：sjzxyx88@126.com |
|
